that was my concern, when they played that acquisition card. thank you for summarising.
- Forums
- ASX - By Stock
- IFL
- Ann: IOOF Q2 2021 Business Update
Ann: IOOF Q2 2021 Business Update, page-34
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IFL (ASX) to my watchlist
|
|||||
Last
$2.40 |
Change
0.040(1.69%) |
Mkt cap ! $1.609B |
Open | High | Low | Value | Volume |
$2.39 | $2.43 | $2.39 | $3.581M | 1.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 4622 | $2.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.41 | 10582 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 330 | 2.450 |
6 | 8557 | 2.400 |
1 | 7200 | 2.390 |
3 | 48980 | 2.380 |
5 | 24680 | 2.370 |
Price($) | Vol. | No. |
---|---|---|
2.210 | 3050 | 1 |
2.310 | 41 | 4 |
2.340 | 201 | 4 |
2.390 | 6678 | 2 |
2.400 | 7373 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IFL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online